Renvela
Product Images NDC 68151-5113

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Renvela (NDC 68151-5113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl681515113)

Renvela is a medication containing sevelamer carbonate manufactured by Genzyme. This medication comes in the form of an 800 mg tablet and is associated with the lot number B3548B01 and the expiration date of 09/14. The remaining text is not readable due to errors.*

FDA Label Image

Chemical Structure/figure 1 (Renvela 01)

This appears to be a diagram showing the chemical structure of a molecule consisting of two amino groups (NH2) connected by a single nitrogen atom (NH) and a hydroxyl group (OH). The compound is not specified, but it is likely an organic molecule.*

FDA Label Image

Figure 2 (Renvela 02)

This appears to be a graph or chart displaying the reduction of serum phosphorus levels in patients using Sevelamer Hydrochloride compared to an active control. The graph contains information on the percentage of patients who experienced improvement or worsened levels of serum phosphorus and the reduction from the baseline. The X-axis displays the reduction in serum phosphorus levels (measured in mg/dL) while the Y-axis appears to be a combination of patient numbers and various labels that are not clear due to the output.*

FDA Label Image

Figure 3 (Renvela 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.